Chemoinformaics analysis of 1,4-Dihydroxyanthraquinone
| Molecular Weight | 240.214 | nRot | 0 |
| Heavy Atom Molecular Weight | 232.15 | nRig | 18 |
| Exact Molecular Weight | 240.042 | nRing | 3 |
| Solubility: LogS | -4.099 | nHRing | 0 |
| Solubility: LogP | 3.318 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 31.9223 |
| nHD | 2 | BPOL | 9.76166 |
| QED | 0.692 |
| Synth | 2.361 |
| Natural Product Likeliness | 0.797 |
| NR-PPAR-gamma | 0.958 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0 |
| HIA | 0.167 |
| CACO-2 | -4.944 |
| MDCK | 0.0000142 |
| BBB | 0.045 |
| PPB | 0.998223 |
| VDSS | 0.359 |
| FU | 0.0126604 |
| CYP1A2-inh | 0.979 |
| CYP1A2-sub | 0.119 |
| CYP2c19-inh | 0.15 |
| CYP2c19-sub | 0.09 |
| CYP2c9-inh | 0.489 |
| CYP2c9-sub | 0.468 |
| CYP2d6-inh | 0.605 |
| CYP2d6-sub | 0.27 |
| CYP3a4-inh | 0.455 |
| CYP3a4-sub | 0.112 |
| CL | 4.683 |
| T12 | 0.433 |
| hERG | 0.01 |
| Ames | 0.844 |
| ROA | 0.774 |
| SkinSen | 0.922 |
| Carcinogencity | 0.762 |
| EI | 0.96 |
| Respiratory | 0.433 |
| NR-Aromatase | 0.833 |
| Antiviral | Yes |
| Prediction | 0.709549 |